 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 10, 2022 GLOBE NEWSWIRE -- F-star Therapeutics, Inc. NASDAQ: FSTX, a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced that management will be presenting a corporate overview and be available for 1-on-1 meetings at the 32nd Annual Oppenheimer Healthcare Conference taking place virtually on March 15-17, 2022. 